Related Experiment Video
Updated: Jul 27, 2026
15:02
Preparation and Culture of Rat Lens Epithelial Explants for Studying Terminal Differentiation
Published on: September 22, 2009
Characterisation of TGF-beta2 signalling and function in a human lens cell line
I M Wormstone1, S Tamiya, J A Eldred
1School of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, UK.
Experimental Eye Research
|April 27, 2004
Summary
Transforming growth factor beta (TGF-beta) signaling in human lens cells drives pathological changes. A novel antibody, CAT-152, effectively inhibits TGF-beta2-induced cellular responses, offering potential therapeutic benefits.
Area of Science:
- Ophthalmology
- Cell Biology
- Molecular Signaling
Background:
- Transforming growth factor beta (TGF-beta) is implicated in lens pathology.
- Human lens cell signaling mechanisms, particularly those involving TGF-beta, require further elucidation.
- Understanding these pathways is crucial for addressing lens-related diseases.
Purpose of the Study:
- To investigate the signaling characteristics of TGF-beta and Smad proteins in a human lens cell line (FHL 124).
- To evaluate the efficacy of a monoclonal anti-TGF-beta2 antibody (CAT-152) in suppressing TGF-beta2-induced cellular alterations.
- To establish a platform for studying TGF-beta2 signaling in human lens epithelial cells.
Main Methods:
- Characterization of FHL 124 cells using gene microarrays and phenotypic marker analysis.
- Assessment of Smad 4 localization via immunocytochemistry.
- Measurement of Smad-dependent transcriptional activity using a luciferase reporter assay (SBE4-luc).
- Analysis of gene expression (alphaSMA, CTGF) by RT-PCR.
- Evaluation of cell proliferation (3H-thymidine incorporation) and contraction (scratch/patch assay).
Main Results:
- FHL 124 cells exhibit high homology (99.5%) to native human lens epithelium and express key markers (alphaA-crystallin, pax6, FoxE3).
- TGF-beta2 exposure induced Smad 4 nuclear translocation, stimulated Smad-dependent transcription, and increased alphaSMA and CTGF mRNA levels.
- TGF-beta2 promoted cell contraction and enhanced proliferation in serum-supplemented media; CAT-152 dose-dependently inhibited these TGF-beta2 effects.
Conclusions:
- TGF-beta2 signaling in human lens epithelial cells leads to Smad activation, gene expression changes, and significant cellular contraction.
- The anti-TGF-beta2 antibody CAT-152 effectively suppresses TGF-beta2-induced responses in vitro.
- TGF-beta2 is a potent factor in the development of posterior capsule opacification, and CAT-152 shows therapeutic potential.
